The latest news from MIMS, Medical Observer and myDr.com.au along with industry press releases of interest to MIMS subscribers.

An Australian First
As an Australian first, MIMS has partnered with UnityHealth to bring an Australian evidence-based Complementary V Mainstream drug interaction module to market, via its eMIMS product.

96% of eMIMS users have indicated that they are concerned about interactions between prescription medicines & complementary medicines, stating that this interactions module gives them more confidence in making a safer choice for their patients.

Click here to read the full press release.

 

MIMS announced today that the company, as an Australian first, has partnered with UnityHealth to bring an Australian evidence based Complementary V Mainstream drug interaction module to market.

Surveys by the National Prescribing Service have found that safety and interactions between herbal medicines and prescription drugs are amongst the information most required by health professionals. Furthermore, results of the surveys showed half the people who reported the use of complementary and alternative medicines also used conventional medicines on the same day, while the majority of usages were not reported to doctors.

Click here to read the full press release.

MIMS contributes to PSS development fund
The development and expansion of the Pharmacists’ Support Service (PSS) has been given a boost through a generous donation of $2000 from MIMS. The donation will be put towards developing a Pharmacists’ Support Service website which will include a host of resources and information to support and assist pharmacists.

Click here to read the full press release.